Smithfield Trust’s Genomic Health, Inc. GHDX Stock Holding History

Smithfield Trust’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-100	Closed	-$7K	–	1024
2019 Q3	$7K	Hold	100	–	–	﹤0.01%	790
2019 Q2	$6K	Hold	100	–	–	﹤0.01%	797
2019 Q1	$7K	Hold	100	–	–	﹤0.01%	729
2018 Q4	$6K	Hold	100	–	–	﹤0.01%	739
2018 Q3	$7K	Hold	100	–	–	﹤0.01%	787
2018 Q2	$5K	Hold	100	–	–	﹤0.01%	835
2018 Q1	$3K	Hold	100	–	–	﹤0.01%	960
2017 Q4	$3K	Hold	100	–	–	﹤0.01%	1000
2017 Q3	$3K	Hold	100	–	–	﹤0.01%	786
2017 Q2	$3K	Hold	100	–	–	﹤0.01%	779
2017 Q1	$3K	Buy	+100	New	+$2.96K	﹤0.01%	764

Smithfield Trust's GHDX Position: Q4 2019 in Review

Smithfield Trust sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 100 shares — an estimated $7K sold.

Smithfield Trust first reported a position in GHDX in Q1 2017 and held it in 11 quarters. The position peaked at $7K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Smithfield Trust reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Smithfield Trust sold 100 Genomic Health, Inc. shares in Q4 2019, an estimated $7K.
Smithfield Trust first reported a position in Genomic Health, Inc. in Q1 2017 and held it in 11 quarters.
Smithfield Trust's Genomic Health, Inc. position peaked at $7K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Smithfield Trust's 13F filing for Q4 2019, filed 13 Feb 2020.